Clinical Trials
3 trialsNCT00804154 2026-05-01
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Recruiting
NCT02522611 2026-04-13
Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain
National Institutes of Health Clinical Center (CC)
Phase 1/2 Not yet recruiting
NCT06940570 2025-10-23
MATCH
University of Texas Southwestern Medical Center
Phase 3 Suspended